D20.215.894

5 trials

Sponsors

Universidade Federal de São Paulo, Instituto Nacional de Infectologia Evandro Chagas - INI/FIOCRUZ, Faculdade de Enfermagem da Universidade Federal de Goiás, Instituto de Tecnologia em Imunobiológicos Bio-Manguinhos / Fiocruz, Secretaria Municipal de Saúde do Rio de Janeiro

Conditions

LeprosyMonkeypoxVaccine against DengueViruses, Vaccination, Pain measurement, Nursing Education, Child Healthautoimmune diseases

Phase 2

Study Aimed at Assessing whether the Vaccine is safe, how much the body tolerates and how much the immune system reacts to the LEP-F1 + GLA-SE Vaccine in adult participants in a region where there are many patients with leprosy

Active, not recruitingRBR-88jm8yk

Instituto de Tecnologia em Imunobiológicos Bio-Manguinhos / FiocruzLeprosy

Start: 2022-01-04Updated: 2025-10-27

Phase 4

Clinical trial to evaluate monkeypox vaccine response in persons previously exposed to monkeypox virus

RecruitingRBR-10mpz6sd

Instituto Nacional de Infectologia Evandro Chagas - INI/FIOCRUZMonkeypox

Start: 2022-12-13Updated: 2025-10-27

Unknown Phase

Evaluation of safety, effectiveness and duration of immunity after vaccination against Covid-19 in patients with autoimmune rheumatic diseases

Active, not recruitingRBR-108fyykd

Universidade Federal de São Pauloautoimmune diseases

Start: 2021-04-27Updated: 2025-10-27

Adverse events evaluation of vaccine against diphtheria, tetanus and whooping cough in children in the city of Goiania - Goias

Active, not recruitingRBR-6c4c6hk

Faculdade de Enfermagem da Universidade Federal de GoiásViruses, Vaccination, Pain measurement, Nursing Education, Child Health

Start: 2012-11-12Updated: 2025-10-27

Effectiveness of the vaccine that protects against four different types of the dengue virus (QdengA) in the Municipality of Rio de Janeiro

RecruitingRBR-9j53g4r

Secretaria Municipal de Saúde do Rio de JaneiroVaccine against Dengue

Start: 2024-02-16Updated: 2025-10-27

Related Papers

Comparison of the immunogenicity and safety among COVID-19 vaccines ChadOx-1, CoronaVac and BNT162b2 in systemic lupus erythematosus (SLE) patients: a prospective cohort.

2025-11-22